Prognostic Value of SYNTAX Score in Patients With Infarct -Related Cardiogenic Shock Insights From the CULPRIT -SHOCK Trial

被引:18
作者
Guedeney, Paul [1 ]
Barthelemy, Olivier [1 ]
Zeitouni, Michel [1 ]
Hauguel-Moreau, Marie [1 ]
Hage, Georges [1 ]
Kerneis, Mathieu [1 ]
Lattuca, Benoit [1 ]
Overtchouk, Pavel [1 ]
Rouanet, Stephanie [2 ]
Fuernau, Georg [3 ]
de Waha-Thiele, Suzanne [3 ]
Zeymer, Uwe [4 ]
Sandri, Marcus [5 ]
Akin, Ibrahim [6 ]
Desch, Steffen [5 ]
Thiele, Holger [5 ]
Montalescot, Gilles [1 ]
机构
[1] Sorbonne Univ, AP HP, ACT Study Grp, INSERM UMRS 1166,Inst Cardiol, Paris, France
[2] StatEthic, Statistician Unit, ACT Study Grp, Levallois Perret, France
[3] Univ Heart Ctr Lubeck, Lubeck, Germany
[4] Klinikum Ludwigshafen, Inst Herzinfarktforsch, Ludwigshafen, Germany
[5] Univ Leipzig, Leipzig Heart Inst, Heart Ctr Leipzig, Leipzig, Germany
[6] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med Cardiol 1, Mannheim, Germany
关键词
PERCUTANEOUS CORONARY INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; CARDIAC-SURGERY SCORE; ACUTE CATHETERIZATION; 3-VESSEL DISEASE; FOLLOW-UP; OUTCOMES; RISK; REVASCULARIZATION; SYNERGY;
D O I
10.1016/j.jcin.2020.04.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to evaluate the prognostic value of the SYNTAX (SYNergy between PCI with TAXUS and Cardiac Surgery) scores in patients undergoing percutaneous coronary intervention (PCI) for multivessel coronary disease with infarct-related cardiogenic shock (CS). BACKGROUND The prognostic value of the SYNTAX score in this high-risk setting remains unclear. METHODS The CULPRIT-SHOCK (Culprit Lesion Only PCI versus Multivessel PCI in Cardiogenic Shock) trial was an international, open-label trial, where patients presenting with infarct-related CS and multivessel disease were randomized to a culprit-lesion-only or an immediate multivessel PCI strategy. Baseline SYNTAX score was assessed by a central core laboratory and categorized as low SYNTAX score (SS #22), intermediate SYNTAX score (22<SS#32) and high SYNTAX score (SS>32). Adjudicated endpoints of interest were the 30-day risk of death or renal replacement therapy (RRT) and 1-year death. Associations between baseline SYNTAX score and outcomes were assessed using multivariate logistic regression. RESULTS Pre-PCI SYNTAX score was available in 624 patients, of whom 263 (42.1%), 207 (33.2%) and 154 (24.7%) presented with low, intermediate and high SYNTAX score, respectively. A stepwise increase in the incidence of adverse events was observed from low to intermediate and high SYNTAX score for the 30-day risk of death or RRT and the 1-year risk of death (p < 0.001, for all). After multiple adjustments, intermediate and high SYNTAX score remained strongly associated with 30-day risk of death or renal replacement therapy and 1-year risk of all-cause death. There was no significant interaction between SYNTAX score and the coronary revascularization strategy for any outcomes. CONCLUSIONS In patients presenting with multivessel disease and infarct-related CS, the SYNTAX score was strongly associated with 30-day death or RRT and 1-year mortality.
引用
收藏
页码:1198 / 1206
页数:9
相关论文
共 31 条
[1]   Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification [J].
Bartholomew, BA ;
Harjai, KJ ;
Dukkipati, S ;
Boura, JA ;
Yerkey, MW ;
Glazier, S ;
Grines, CL ;
O'Neill, WW .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (12) :1515-1519
[2]   Global Risk Classification and Clinical SYNTAX (Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery) Score in Patients Undergoing Percutaneous or Surgical Left Main Revascularization [J].
Capodanno, Davide ;
Caggegi, Anna ;
Miano, Marco ;
Cincotta, Glauco ;
Dipasqua, Fabio ;
Giacchi, Giuseppe ;
Capranzano, Piera ;
Ussia, Gianpaolo ;
Di Salvo, Maria Elena ;
La Manna, Alessio ;
Tamburino, Corrado .
JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (03) :287-297
[3]   Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial [J].
Chichareon, Ply ;
Onuma, Yoshinobu ;
Van Klaveren, David ;
Modolo, Rodrigo ;
Kogame, Norihiro ;
Takahashi, Kuniaki ;
Chang, Chun Chin ;
Tomaniak, Mariusz ;
Asano, Taku ;
Katagiri, Yuki ;
Van Geuns, Robert-Jan ;
Bolognese, Leonardo ;
Tumscitz, Carlo ;
Vrolix, Mathias ;
Petrov, Ivo ;
Garg, Scot ;
Naber, Christoph Kurt ;
Sabate, Manel ;
Iqbal, Javaid ;
Wykrzykowska, Joanna J. ;
Piek, Jan J. ;
Spitzer, Ernest ;
Juni, Peter ;
Hamm, Christian W. ;
Steg, Gabriel ;
Valgimigli, Marco ;
Vranckx, Pascal ;
Windecker, Stephan ;
Serruys, Patrick W. .
EUROINTERVENTION, 2019, 15 (06) :E539-+
[4]   Prediction, staging, and outcomes of ischaemic cardiogenic shock after STEMI: a complex clinical interplay [J].
Dangas, G. ;
Guedeney, P. .
EUROPEAN HEART JOURNAL, 2018, 39 (22) :2103-2105
[5]   Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention [J].
De Servi, Stefano ;
Crimi, Gabriele ;
Calabro, Paolo ;
Piscione, Federico ;
Cattaneo, Marco ;
Maffeo, Diego ;
Toso, Anna ;
Bartorelli, Antonio ;
Palmieri, Cataldo ;
De Carlo, Marco ;
Capodanno, Davide ;
Barozzi, Chiara ;
Tomasi, Luciana ;
Della Riva, Diego ;
Angiolillo, Dominick J. ;
Palmerini, Tullio .
EUROINTERVENTION, 2016, 12 (03) :312-318
[6]   Renal function, atherothrombosis extent, and outcomes in high-risk patients [J].
Dumaine, Raphaelle L. ;
Montalescot, Gilles ;
Steg, Ph. Gabriel ;
Ohman, E. Magnus ;
Eagle, Kim ;
Bhatt, Deepak L. .
AMERICAN HEART JOURNAL, 2009, 158 (01) :141-U11
[7]   The Prognostic Utility of the SYNTAX Score on 1-Year Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents A Substudy of the RESOLUTE All Comers Trial [J].
Garg, Scot ;
Serruys, Patrick W. ;
Silber, Sigmund ;
Wykrzykowska, Joanna ;
van Geuns, Robert Jan ;
Richardt, Gert ;
Buszman, Pawel E. ;
Kelbaek, Henning ;
van Boven, Adrianus Johannes ;
Hofma, Sjoerd H. ;
Linke, Axel ;
Klauss, Volker ;
Wijns, William ;
Macaya, Carlos ;
Garot, Philippe ;
DiMario, Carlo ;
Manoharan, Ganesh ;
Kornowski, Ran ;
Ischinger, Thomas ;
Bartorelli, Antonio ;
Van Remortel, Eric ;
Ronden, Jacintha ;
Windecker, Stephan .
JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (04) :432-441
[8]   Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease [J].
Guedeney, Paul ;
Sorrentino, Sabato ;
Vogel, Birgit ;
Baber, Usman ;
Claessen, Bimmer E. ;
Mehran, Roxana .
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2018, 16 (11) :825-835
[9]   Risk Profile and 3-Year Outcomes From the SYNTAX Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Nested Registries [J].
Head, Stuart J. ;
Holmes, David R., Jr. ;
Mack, Michael J. ;
Serruys, Patrick W. ;
Mohr, Friedrich W. ;
Morice, Marie-Claude ;
Colombo, Antonio ;
Kappetein, A. Pieter .
JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (06) :618-625
[10]   Revascularization in stable coronary artery disease: a combined perspective from an interventional cardiologist and a cardiac surgeon [J].
Holmes, David R., Jr. ;
Taggart, David P. .
EUROPEAN HEART JOURNAL, 2016, 37 (24) :1873-1882